Clinical Trial Update: Safety, Tolerability,Pharmacokinetics(PK)and Pharmacodynamics(PD)Assessment of LCQ908 in Patients With Severe Hypertriglyceridemia [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update assessing safety, tolerability, PK, and PD of LCQ908 in patients with severe hypertriglyceridemia across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipoproteinemia
• Hypertriglyceridemia

Drugs mentioned

• LCQ908

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hyperlipoproteinemia | Phase 1, Phase 2 | Status: COMPLETED